APAC Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Description

List of Tables

The Asia-Pacific pancreatic cancer diagnostics market is projected to register a substantial CAGR of 7.2% from 2023 to 2030. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2023 to 2030.

Market Segmentation:

Asia-Pacific Pancreatic Cancer Diagnostics Market, By Test Type (Imaging Test, Biopsy, Blood Test, Genomic Test, and Others), Cancer Stage (Stage 0, Stage I, Stage II, Stage III and Stage IV), Tumor Type(Exocrine Tumors and Neuroendocrine Tumors), Product (Instrument-Based Products, Platform-Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluorimmunoassay, Comparative Genomic Hybridization, Immunohistochemical, and Others), Application(Screening, Diagnostic and Predictive, Prognostic, and Research), End User (Hospitals, Diagnostic Centers, Cancer Research Centers, Academic Institutes, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (China, Japan, India, Australia, New Zealand, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Taiwan and the Rest of Asia-Pacific) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of pancreatic cancer diagnostics market are:

Rise in prevalence and incidence of pancreatic cancer

Increase in awareness about the pancreatic cancer diagnostics

Market Players:

Some of the major players operating in the Asia-Pacific pancreatic cancer diagnostics market are:

Canon Medical Systems ANZ Pty Limited.

Koninklijke Philips N.V.

Siemens Healthcare Private Limited

Myriad Genetics, Inc.

Boditech Med Inc.

Abbott

Agilent Technologies, Inc.

Thermo Fisher Scientific

QIAGEN

MP BIOMEDICALS

Laboratory Corporation of America Holdings

AccuBioTech Co., Ltd.

Setia Scientific Solution

Meridian Life Science, Inc.

1 INTRODUCTION 91

1.1 OBJECTIVES OF THE STUDY 91
1.2 MARKET DEFINITION 91
1.3 OVERVIEW OF THE ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET 91
1.4 CURRENCY AND PRICING 94
1.5 LIMITATIONS 94
1.6 MARKETS COVERED 94

2 MARKET SEGMENTATION 98

2.1 MARKETS COVERED 98
2.2 GEOGRAPHICAL SCOPE 99
2.3 YEARS CONSIDERED FOR THE STUDY 100
2.4 DBMR TRIPOD DATA VALIDATION MODEL 101
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 104
2.6 MULTIVARIATE MODELLING 105
2.7 MARKET END USER COVERAGE GRID 106
2.8 PRODUCT LIFELINE CURVE 107
2.9 DBMR MARKET POSITION GRID 108
2.10 VENDOR SHARE ANALYSIS 109
2.11 SECONDARY SOURCES 110
2.12 ASSUMPTIONS 110

3 EXECUTIVE SUMMARY 111

4 PREMIUM INSIGHTS 114

4.1 PESTEL ANALYSIS 115
4.2 PORTER'S FIVE FORCES MODEL 116

5 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, INDUSTRY INSIGHTS 117

6 EPIDEMIOLOGY 119

7 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, REGULATIONS 120

8 MARKET OVERVIEW 123

8.1 DRIVERS 125
- 8.1.1 GROW IN PREVALENCE OF PANCREATIC CANCER 125
- 8.1.2 NOVEL TECHNOLOGICAL ADVANCEMENTS IN PANCREATIC DIAGNOSTICS 125
- 8.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 126
- 8.1.4 INCREASE IN AWARENESS REGARDING PANCREATIC CANCER 126
8.2 RESTRAINTS 127
- 8.2.1 STRICT REGULATIONS AND STANDARDS FOR THE APPROVAL AND COMMERCIALIZATION OF PANCREATIC CANCER DIAGNOSTIC PRODUCTS 127
- 8.2.2 LATE DIAGNOSIS AND POOR PROGNOSIS OF PANCREATIC CANCER 127
8.3 OPPORTUNITIES 128
- 8.3.1 INCREASE IN DIAGNOSTIC PRODUCTS FOR PANCREATIC CANCER 128
- 8.3.2 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 129
- 8.3.3 GOVERNMENT INITIATIVES TOWARD PANCREATIC CANCER DIAGNOSTICS 129
8.4 CHALLENGES 130
- 8.4.1 INCREASED COST, SAFETY, AND CONVENIENCE ISSUES 130
- 8.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 130

9 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE 131

9.1 OVERVIEW 132
9.2 IMAGING TEST 135
- 9.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 136
- 9.2.2 MAGNETIC RESONANCE IMAGING (MRI) 136
  - 9.2.2.1 MR CHOLANGIOPANCREATOGRAPHY 136
  - 9.2.2.2 MR ANGIOGRAPHY (MRA) 137
- 9.2.3 ULTRASOUND 137
  - 9.2.3.1 ABDOMINAL ULTRASOUND 137
  - 9.2.3.2 ENDOSCOPIC ULTRASOUND (EUS) 137
- 9.2.4 CHOLANGIOPANCREATOGRAPHY 137
  - 9.2.4.1 MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY (MRCP) 138
  - 9.2.4.2 ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY (ERCP) 138
  - 9.2.4.3 PRECUTANEOUS TRANSHEPTIC CHOLANGIOPANCREATOGRAPHY (PTC) 138
- 9.2.5 POSITRON EMISSION TOMOHRAPHY (PET) 138
- 9.2.6 OTHERS 138
9.3 BIOPSY 139
- 9.3.1 CT-GUIDED NEEDLE BIOPSY 140
- 9.3.2 FINE NEEDLE ASPIRATION (FNA) 140
- 9.3.3 CORE NEEDLE BIOPSY 140
- 9.3.4 OTHERS 140
9.4 BLOOD TEST 140
- 9.4.1 LIVER FUNCTION TEST 141
- 9.4.2 TUMOR MARKER 141
  - 9.4.2.1 CA 19-9 BIOMARKER TEST 142
  - 9.4.2.2 CARCINOEMBROYNIC ANTIGEN (CEA) TEST 142
  - 9.4.2.3 CA 50 MARKER TEST 142
  - 9.4.2.4 OTHERS 142
- 9.4.3 OTHERS 142
9.5 GENOMIC TEST 143
9.6 OTHERS 144

10 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGES 145

10.1 OVERVIEW 146
10.2 STAGE IV 149
10.3 STAGE III 149
10.4 STAGE II 150
- 10.4.1 STAGE IIA 151
- 10.4.2 STAGE IIB 151
10.5 STAGE I 151
- 10.5.1 STAGE IA 152
- 10.5.2 STAGE IB 152
10.6 STAGE 0 153

11 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY TUMOR TYPE 154

11.1 OVERVIEW 155
11.2 EXOCRINE TUMORS 158
- 11.2.1 INSTRUMENT-BASED PRODUCTS 159
- 11.2.2 PLATFORM-BASED PRODUCTS 159
- 11.2.3 KITS AND REAGENTS 159
- 11.2.4 OTHER CONSUMABLES 159
11.3 NEUROENDOCRINE TUMORS 159
- 11.3.1 INSTRUMENT-BASED PRODUCTS 160
- 11.3.2 PLATFORM-BASED PRODUCTS 160
- 11.3.3 KITS AND REAGENTS 161
- 11.3.4 OTHER CONSUMABLES 161

12 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT 162

12.1 OVERVIEW 163
12.2 INSTRUMENT-BASED PRODUCTS 166
- 12.2.1 IMAGING 167
- 12.2.2 BIOPSY 167
12.3 PLATFORM-BASED PRODUCTS 167
- 12.3.1 NEXT-GENERATION SEQUENCING 168
- 12.3.2 MICROARRAYS 168
- 12.3.3 PCR 168
- 12.3.4 OTHERS 169
12.4 KITS AND REAGENTS 169
- 12.4.1 CA19-9 PANCREATIC CANCER TEST KITS 170
  - 12.4.1.1 ELISA TEST KITS 170
  - 12.4.1.2 CASETTE TEST KITS 170
  - 12.4.1.3 OTHERS 170
- 12.4.2 CEA PANCREATIC CANCER TEST KITS 171
  - 12.4.2.1 ELISA TEST KITS 171
  - 12.4.2.2 CASETTE TEST KITS 171
  - 12.4.2.3 OTHERS 171
12.5 OTHER CONSUMABLES 171

13 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY 173

13.1 OVERVIEW 174
13.2 FLUORESCENT IN SITU HYBRIDIZATION 177
13.3 NEXT GENERATION SEQUENCING 178
13.4 FLUORIMMUNOASSAY 179
13.5 COMPARATIVE GENOMIC HYBRIDIZATION 180
13.6 IMMUNOHISTOCHEMICAL 181
13.7 OTHERS 182

14 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY APPLICATION 183

14.1 OVERVIEW 184
14.2 SCREENING 187
- 14.2.1 INSTRUMENT-BASED PRODUCTS 188
- 14.2.2 PLATFORM-BASED PRODUCTS 188
- 14.2.3 KITS AND REAGENTS 188
- 14.2.4 OTHER CONSUMABLES 188
14.3 DIAGNOSTIC AND PREDICTIVE 188
- 14.3.1 INSTRUMENT-BASED PRODUCTS 189
- 14.3.2 PLATFORM-BASED PRODUCTS 189
- 14.3.3 KITS AND REAGENTS 189
- 14.3.4 OTHER CONSUMABLES 189
14.4 PROGNOSTIC 190
- 14.4.1 INSTRUMENT-BASED PRODUCTS 191
- 14.4.2 PLATFORM-BASED PRODUCTS 191
- 14.4.3 KITS AND REAGENTS 191
- 14.4.4 OTHER CONSUMABLES 191
14.5 RESEARCH 191
- 14.5.1 INSTRUMENT-BASED PRODUCTS 192
- 14.5.2 PLATFORM-BASED PRODUCTS 192
- 14.5.3 KITS AND REAGENTS 192
- 14.5.4 OTHER CONSUMABLES 192

15 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY END USER 193

15.1 OVERVIEW 194
15.2 HOSPITALS 197
15.3 DIAGNOSTIC CENTERS 197
15.4 CANCER RESEARCH CENTERS 198
15.5 ACADEMIC INSTITUTES 199
15.6 AMBULATORY SURGICAL CENTERS 200
15.7 OTHERS 201

16 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 202

16.1 OVERVIEW 203
16.2 DIRECT TENDER 206
16.3 RETAIL SALES 207
16.4 OTHERS 208

17 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION 209

17.1 ASIA-PACIFIC 210
- 17.1.1 CHINA 223
- 17.1.2 JAPAN 231
- 17.1.3 INDIA 239
- 17.1.4 SOUTH KOREA 247
- 17.1.5 AUSTRALIA 255
- 17.1.6 TAIWAN 263
- 17.1.7 NEW ZEALAND 271
- 17.1.8 INDONESIA 279
- 17.1.9 THAILAND 287
- 17.1.10 PHILIPPINES 295
- 17.1.11 MALAYSIA 303
- 17.1.12 VIETNAM 311
- 17.1.13 SINGAPORE 319
- 17.1.14 REST OF ASIA-PACIFIC 327

18 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: COMPANY LANDSCAPE 328

18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 328

19 SWOT ANALYSIS 329

20 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET 330

20.1 CANON MEDICAL SYSTEMS CORPORATION 330
- 20.1.1 COMPANY SNAPSHOT 330
- 20.1.2 REVENUE ANALYSIS 330
- 20.1.3 COMPANY SHARE ANALYSIS 331
- 20.1.4 PRODUCT PORTFOLIO 331
- 20.1.5 RECENT DEVELOPMENT 331
20.2 KONINKLIJKE PHILIPS N.V. 332
- 20.2.1 COMPANY SNAPSHOT 332
- 20.2.2 REVENUE ANALYSIS 332
- 20.2.3 COMPANY SHARE ANALYSIS 333
- 20.2.4 PRODUCT PORTFOLIO 333
- 20.2.5 RECENT DEVELOPMENTS 333
20.3 SIEMENS HEALTHCARE GMBH 335
- 20.3.1 COMPANY SNAPSHOT 335
- 20.3.2 REVENUE ANALYSIS 335
- 20.3.3 COMPANY SHARE ANALYSIS 336
- 20.3.4 PRODUCT PORTFOLIO 336
- 20.3.5 RECENT DEVELOPMENT 337
20.4 GRAIL 338
- 20.4.1 COMPANY PROFILE 338
- 20.4.2 COMPANY SHARE ANALYSIS 338
- 20.4.3 PRODUCT PORTFOLIO 339
- 20.4.4 RECENT DEVELOPMENT 339
20.5 MYRIAD GENETICS, INC. 340
- 20.5.1 COMPANY SNAPSHOT 340
- 20.5.2 REVENUE ANALYSIS 340
- 20.5.3 COMPANY SHARE ANALYSIS 341
- 20.5.4 PRODUCT PORTFOLIO 341
- 20.5.5 RECENT DEVELOPMENT 341
20.6 BD 342
- 20.6.1 COMPANY SNAPSHOT 342
- 20.6.2 REVENUE ANALYSIS 342
- 20.6.3 PRODUCT PORTFOLIO 343
- 20.6.4 RECENT DEVELOPMENT 343
20.7 BODITECH MED INC. 344
- 20.7.1 COMPANY PROFILE 344
- 20.7.2 PRODUCT PORTFOLIO 344
- 20.7.3 RECENT DEVELOPMENT 344
20.8 ABBOTT (2022) 345
- 20.8.1 COMPANY SNAPSHOT 345
- 20.8.2 REVENUE ANALYSIS 345
- 20.8.3 PRODUCT PORTFOLIO 346
- 20.8.4 RECENT DEVELOPMENT 346
20.9 FUJIFILM HOLDINGS AMERICA CORPORATION 347
- 20.9.1 COMPANY SNAPSHOT 347
- 20.9.2 REVENUE ANALYSIS 347
- 20.9.3 PRODUCT PORTFOLIO 348
- 20.9.4 RECENT DEVELOPMENT 348
20.10 ACCUBIOTECH CO., LTD. 349
- 20.10.1 COMPANY PROFILE 349
- 20.10.2 PRODUCT PORTFOLIO 349
- 20.10.3 RECENT DEVELOPMENTS 349
20.11 AGILENT TECHNOLOGIES, INC. 350
- 20.11.1 COMPANY PROFILE 350
- 20.11.2 REVENUE ANALYSIS 350
- 20.11.3 PRODUCT PORTFOLIO 351
- 20.11.4 RECENT DEVELOPMENT 351
20.12 CREATIVE BIOLABS. 352
- 20.12.1 COMPANY PROFILE 352
- 20.12.2 PRODUCT PORTFOLIO 352
- 20.12.3 RECENT DEVELOPMENT 352
20.13 CTK BIOTECH, INC. 353
- 20.13.1 COMPANY PROFILE 353
- 20.13.2 PRODUCT PORTFOLIO 353
- 20.13.3 RECENT DEVELOPMENT 353
20.14 DIASOURCE 354
- 20.14.1 COMPANY SNAPSHOT 354
- 20.14.2 PRODUCT PORTFOLIO 354
- 20.14.3 RECENT DEVELOPMENT 354

20.15 LABORATORY CORPORATION OF AMERICA HOLDINGS 355
- 20.15.1 COMPANY SNAPSHOT 355
- 20.15.2 REVENUE ANALYSIS 355
- 20.15.3 PRODUCT PORTFOLIO 356
- 20.15.4 RECENT DEVELOPMENTS 356
20.16 LEE BIOSCIENCE 357
- 20.16.1 COMPANY SNAPSHOT 357
- 20.16.2 PRODUCT PORTFOLIO 357
- 20.16.3 RECENT DEVELOPMENT 357
20.17 MERIDIAN BIOSCIENCE INC. 358
- 20.17.1 COMPANY PROFILE 358
- 20.17.2 PRODUCT PORTFOLIO 358
- 20.17.3 RECENT DEVELOPMENT 358
20.18 MP BIOMEDICALS. 359
- 20.18.1 COMPANY PROFILE 359
- 20.18.2 PRODUCT PORTFOLIO 359
- 20.18.3 RECENT DEVELOPMENTS 359
20.19 QIAGEN 360
- 20.19.1 COMPANY SNAPSHOT 360
- 20.19.2 REVENUE ANALYSIS 360
- 20.19.3 PRODUCT PORTFOLIO 361
- 20.19.4 RECENT DEVELOPMENT 361
20.20 SETIA SCIENTIFIC SOLUTION 362
- 20.20.1 COMPANY PROFILE 362
- 20.20.2 PRODUCT PORTFOLIO 362
- 20.20.3 RECENT DEVELOPMENTS 362
20.21 THERMO FISHER SCIENTIFIC INC. 363
- 20.21.1 COMPANY SNAPSHOT 363
- 20.21.2 REVENUE ANALYSIS 363
- 20.21.3 PRODUCT PORTFOLIO 364
- 20.21.4 RECENT DEVELOPMENT 364

21 QUESTIONNAIRE 365

22 RELATED REPORTS 369

LIST OF TABLES

TABLE 1 APPROVED DIAGNOSTICS OF PANCREATIC CANCER 77
TABLE 2 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 83
TABLE 3 ASIA PACIFIC IMAGING TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 4 ASIA PACIFIC IMAGING TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 85
TABLE 5 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 85
TABLE 6 ASIA PACIFIC ULTRASOUND IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 86
TABLE 7 ASIA PACIFIC CHOLANGIOPANCREATOGRAPHY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 87
TABLE 8 ASIA PACIFIC BIOPSY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 88
TABLE 9 ASIA PACIFIC BIOPSY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 89
TABLE 10 ASIA PACIFIC BLOOD TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 90
TABLE 11 ASIA PACIFIC BLOOD TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 90
TABLE 12 ASIA PACIFIC TUMOR MARKER IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 91
TABLE 13 ASIA PACIFIC GENOMIC TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 92
TABLE 14 ASIA PACIFIC OTHERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
TABLE 15 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGES, 2021-2030 (USD MILLION) 97
TABLE 16 ASIA PACIFIC STAGE IV IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
TABLE 17 ASIA PACIFIC STAGE III IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 99
TABLE 18 ASIA PACIFIC STAGE II IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 100
TABLE 19 ASIA PACIFIC STAGE II IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 100
TABLE 20 ASIA PACIFIC STAGE I IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
TABLE 21 ASIA PACIFIC STAGE I IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 101
TABLE 22 ASIA PACIFIC STAGE 0 IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 102
TABLE 23 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY TUMOR TYPE, 2021-2030 (USD MILLION) 106
TABLE 24 ASIA PACIFIC EXOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 107
TABLE 25 ASIA PACIFIC EXOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 108
TABLE 26 ASIA PACIFIC NEUROENDOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 109
TABLE 27 ASIA PACIFIC NEUROENDOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 28 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 114
TABLE 29 ASIA PACIFIC INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 115
TABLE 30 ASIA PACIFIC INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 116
TABLE 31 ASIA PACIFIC PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 117
TABLE 32 ASIA PACIFIC PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 33 ASIA PACIFIC KITS AND REAGENTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 118
TABLE 34 ASIA PACIFIC KITS AND REAGENTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 35 ASIA PACIFIC CA19-9 PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 119
TABLE 36 ASIA PACIFIC CEA PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 120
TABLE 37 ASIA PACIFIC OTHER CONSUMABLES IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 121
TABLE 38 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 125
TABLE 39 ASIA PACIFIC FLUORESCENT IN SITU HYBRIDIZATION IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 126
TABLE 40 ASIA PACIFIC NEXT GENERATION SEQUENCING IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 127
TABLE 41 ASIA PACIFIC FLUORIMMUNOASSAY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 128
TABLE 42 ASIA PACIFIC COMPARATIVE GENOMIC HYBRIDIZATION IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 129
TABLE 43 ASIA PACIFIC IMMUNOHISTOCHEMICAL IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 130
TABLE 44 ASIA PACIFIC OTHERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 131
TABLE 45 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 135
TABLE 46 ASIA PACIFIC SCREENING IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 136
TABLE 47 ASIA PACIFIC SCREENING IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 136
TABLE 48 ASIA PACIFIC DIAGNOSTIC AND PREDICTIVE IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 138
TABLE 49 ASIA PACIFIC DIAGNOSTIC AND PREDICTIVE IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 138
TABLE 50 ASIA PACIFIC PROGNOSTIC IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 139
TABLE 51 ASIA PACIFIC PROGNOSTIC IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 139
TABLE 52 ASIA PACIFIC RESEARCH IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 141
TABLE 53 ASIA PACIFIC RESEARCH IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 141
TABLE 54 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 145
TABLE 55 ASIA PACIFIC HOSPITALS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 146
TABLE 56 ASIA PACIFIC DIAGNOSTIC CENTERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 147
TABLE 57 ASIA PACIFIC CANCER RESEARCH CENTERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 147
TABLE 58 ASIA PACIFIC ACADEMIC INSTITUTES IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 148
TABLE 59 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 149
TABLE 60 ASIA PACIFIC OTHERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 150
TABLE 61 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 154
TABLE 62 ASIA PACIFIC DIRECT TENDER IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 155
TABLE 63 ASIA PACIFIC RETAIL SALES IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 156
TABLE 64 ASIA PACIFIC OTHERS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 157
TABLE 65 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 164
TABLE 66 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 164
TABLE 67 ASIA-PACIFIC IMAGING TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 164
TABLE 68 ASIA-PACIFIC MAGNETIC RESONANCE IMAGING (MRI) IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
TABLE 69 ASIA-PACIFIC ULTRASOUND IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
TABLE 70 ASIA-PACIFIC CHOLANGIOPANCREATOGRAPHY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
TABLE 71 ASIA-PACIFIC BLOOD TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 165
TABLE 72 ASIA-PACIFIC TUMOR MARKER IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 166
TABLE 73 ASIA-PACIFIC BIOPSY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 166
TABLE 74 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 166
TABLE 75 ASIA-PACIFIC STAGE I IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 166
TABLE 76 ASIA-PACIFIC STAGE II IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 167
TABLE 77 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY TUMOR TYPE, 2021-2030 (USD MILLION)

167

TABLE 78 ASIA-PACIFIC EXOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 167
TABLE 79 ASIA-PACIFIC NEUROENDOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 167
TABLE 80 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 168
TABLE 81 ASIA-PACIFIC INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 168
TABLE 82 ASIA-PACIFIC INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (UNITS) 168
TABLE 83 ASIA-PACIFIC INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD) 168
TABLE 84 ASIA-PACIFIC PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 168
TABLE 85 ASIA-PACIFIC PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (UNITS) 169
TABLE 86 ASIA-PACIFIC PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD) 169
TABLE 87 ASIA-PACIFIC KITS AND REAGENTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 169
TABLE 88 ASIA-PACIFIC CA19-9 PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 169
TABLE 89 ASIA-PACIFIC CEA PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 169
TABLE 90 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 170
TABLE 91 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 170
TABLE 92 ASIA-PACIFIC SCREENING IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 170
TABLE 93 ASIA-PACIFIC DIAGNOSTIC AND PREDICTIVE IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 170
TABLE 94 ASIA-PACIFIC PROGNOSTIC IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 171
TABLE 95 ASIA-PACIFIC RESEARCH IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 171
TABLE 96 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 171
TABLE 97 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 171
TABLE 98 CHINA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 172
TABLE 99 CHINA IMAGING TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 172
TABLE 100 CHINA MAGNETIC RESONANCE IMAGING (MRI) IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 172
TABLE 101 CHINA ULTRASOUND IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 172
TABLE 102 CHINA CHOLANGIOPANCREATOGRAPHY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 173
TABLE 103 CHINA BLOOD TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 173
TABLE 104 CHINA TUMOR MARKER IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 173
TABLE 105 CHINA BIOPSY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 173
TABLE 106 CHINA PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 174
TABLE 107 CHINA STAGE I IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 174
TABLE 108 CHINA STAGE II IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 174
TABLE 109 CHINA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TUMOR TYPE, 2021-2030 (USD MILLION) 174
TABLE 110 CHINA EXOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 174
TABLE 111 CHINA NEUROENDOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 175
TABLE 112 CHINA PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 175
TABLE 113 CHINA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 175
TABLE 114 CHINA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (UNITS) 175
TABLE 115 CHINA INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD) 175
TABLE 116 CHINA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 176
TABLE 117 CHINA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (UNITS) 176
TABLE 118 CHINA PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD) 176
TABLE 119 CHINA KITS AND REAGENTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 176
TABLE 120 CHINA CA19-9 PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 176
TABLE 121 CHINA CEA PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 177
TABLE 122 CHINA PANCREATIC CANCER DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION) 177
TABLE 123 CHINA PANCREATIC CANCER DIAGNOSTICS MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 177
TABLE 124 CHINA SCREENING IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 177
TABLE 125 CHINA DIAGNOSTIC AND PREDICTIVE IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 178
TABLE 126 CHINA PROGNOSTIC IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 178
TABLE 127 CHINA RESEARCH IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 178
TABLE 128 CHINA PANCREATIC CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 178
TABLE 129 CHINA PANCREATIC CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 179
TABLE 130 JAPAN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 180
TABLE 131 JAPAN IMAGING TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 180
TABLE 132 JAPAN MAGNETIC RESONANCE IMAGING (MRI) IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 180
TABLE 133 JAPAN ULTRASOUND IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 180
TABLE 134 JAPAN CHOLANGIOPANCREATOGRAPHY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
TABLE 135 JAPAN BLOOD TEST IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
TABLE 136 JAPAN TUMOR MARKER IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
TABLE 137 JAPAN BIOPSY IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 181
TABLE 138 JAPAN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 182
TABLE 139 JAPAN STAGE I IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 182
TABLE 140 JAPAN STAGE II IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY CANCER STAGE, 2021-2030 (USD MILLION) 182
TABLE 141 JAPAN PANCREATIC CANCER DIAGNOSTICS MARKET, BY TUMOR TYPE, 2021-2030 (USD MILLION) 182
TABLE 142 JAPAN EXOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 182
TABLE 143 JAPAN NEUROENDOCRINE TUMORS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 183
TABLE 144 JAPAN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 183
TABLE 145 JAPAN INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 183
TABLE 146 JAPAN INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (UNITS) 183
TABLE 147 JAPAN INSTRUMENT-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD) 183
TABLE 148 JAPAN PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 184
TABLE 149 JAPAN PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (UNITS) 184
TABLE 150 JAPAN PLATFORM-BASED PRODUCTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD) 184
TABLE 151 JAPAN KITS AND REAGENTS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 184
TABLE 152 JAPAN CA19-9 PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 184
TABLE 153 JAPAN CEA PANCREATIC CANCER TEST KITS IN PANCREATIC CANCER DIAGNOSTICS MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 185

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: SEGMENTATION 46
FIGURE 2 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 49
FIGURE 3 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 50
FIGURE 4 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS 51
FIGURE 5 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 51
FIGURE 6 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 52
FIGURE 7 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: MARKET END USER COVERAGE GRID 54
FIGURE 8 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 56
FIGURE 9 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 57
FIGURE 10 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: SEGMENTATION 61
FIGURE 11 GROWING AWARENESS OF PANCREATIC CANCER AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET FROM 2023 TO 2030 62
FIGURE 12 IMAGING TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET IN 2023 & 2030 62
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET 72
FIGURE 14 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 80
FIGURE 15 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 81
FIGURE 16 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 81
FIGURE 17 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 82
FIGURE 18 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2022 94
FIGURE 19 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, 2023-2030 (USD MILLION) 95
FIGURE 20 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, CAGR (2023-2030) 95
FIGURE 21 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY CANCER STAGES, LIFELINE CURVE 96
FIGURE 22 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TUMOR TYPE, 2022 103
FIGURE 23 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TUMOR TYPE, 2023-2030 (USD MILLION) 104
FIGURE 24 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TUMOR TYPE, CAGR (2023-2030) 104
FIGURE 25 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TUMOR TYPE, LIFELINE CURVE 105
FIGURE 26 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY PRODUCT, 2022 111
FIGURE 27 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY PRODUCT, 2023-2030 (USD MILLION) 112
FIGURE 28 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY PRODUCT, CAGR (2023-2030) 112
FIGURE 29 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY PRODUCT, LIFELINE CURVE 113
FIGURE 30 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, 2022 122
FIGURE 31 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, 2023-2030 (USD MILLION) 123
FIGURE 32 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, CAGR (2023-2030) 123
FIGURE 33 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TECHNOLOGY, LIFELINE CURVE 124
FIGURE 34 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY APPLICATION, 2022 132
FIGURE 35 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 133
FIGURE 36 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2023-2030) 133
FIGURE 37 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE 134
FIGURE 38 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY END USER, 2022 142
FIGURE 39 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 143
FIGURE 40 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 143
FIGURE 41 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 144
FIGURE 42 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 151
FIGURE 43 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 152
FIGURE 44 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 152
FIGURE 45 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 153
FIGURE 46 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 159
FIGURE 47 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 161
FIGURE 48 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 161
FIGURE 49 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 162
FIGURE 50 ASIA-PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: BY TEST TYPE (2023-2030) 162
FIGURE 51 ASIA PACIFIC PANCREATIC CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 276